Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Gains from Investment Securities (2016 - 2025)

Akebia Therapeutics has reported Gains from Investment Securities over the past 10 years, most recently at $2.8 million for Q4 2025.

  • Quarterly Gains from Investment Securities rose 737.27% to $2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.2 million through Dec 2025, up 1646.05% year-over-year, with the annual reading at $2.6 million for FY2025, 694.55% up from the prior year.
  • Gains from Investment Securities was $2.8 million for Q4 2025 at Akebia Therapeutics, up from -$1.5 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $26.7 million in Q4 2022 and troughed at -$11.0 million in Q3 2022.
  • The 4-year median for Gains from Investment Securities is -$762500.0 (2021), against an average of $477625.0.
  • Year-over-year, Gains from Investment Securities crashed 25245.45% in 2021 and then soared 2917.55% in 2022.
  • A 4-year view of Gains from Investment Securities shows it stood at -$946000.0 in 2021, then soared by 2917.55% to $26.7 million in 2022, then crashed by 98.76% to $330000.0 in 2024, then skyrocketed by 737.27% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for AKBA's Gains from Investment Securities are $2.8 million (Q4 2025), -$1.5 million (Q3 2025), and $7.0 million (Q2 2025).